N07.3 Hereditary nephropathy, not elsewhere classified with diffuse mesangial proliferative glomerulonephritis

Name of the Condition

• Hereditary Nephropathy, Not Elsewhere Classified with Diffuse Mesangial Proliferative Glomerulonephritis
• ICD-10 Code: N07.3

Summary

Hereditary nephropathy, not elsewhere classified with diffuse mesangial proliferative glomerulonephritis, is a genetic kidney disorder characterized by inherited diffuse mesangial proliferative changes in the glomeruli, the kidney's filtering units. This condition involves abnormal growth of mesangial cells and increased mesangial matrix, leading to impaired filtration. Symptoms may include proteinuria, hematuria, and progressive renal dysfunction, though presentation varies. Management focuses on slowing disease progression and addressing complications.

Causes

This condition results from genetic mutations affecting kidney structure or function, often inherited in an autosomal dominant or recessive pattern. The mutations disrupt normal glomerular development or function, leading to diffuse mesangial proliferation. While specific genetic defects may be identified in some cases, others remain uncharacterized, and the diagnosis is made when hereditary kidney disease does not align with more defined subtypes.

Risk Factors

• Family history of kidney disease: A genetic predisposition increases risk.
• Consanguinity: Higher likelihood of recessive genetic disorders in closely related families.
• Specific genetic mutations: Inherited defects in genes related to glomerular structure or function.

Symptoms

• Hematuria (blood in urine), which may be microscopic or visible.
• Proteinuria (excess protein in urine), potentially causing foamy urine.
• Hypertension (high blood pressure).
• Reduced kidney function, which may progress over time.
• Edema (swelling) in some cases.

Diagnosis

Diagnosis involves urinalysis to detect blood and protein, blood tests to assess kidney function (e.g., creatinine, BUN), and imaging studies to evaluate kidney structure. A kidney biopsy is often performed to confirm diffuse mesangial proliferative glomerulonephritis and rule out other causes. Genetic testing may be considered to identify underlying mutations, though this is not always definitive.

Treatment Options

Treatment focuses on managing symptoms and slowing disease progression. This may include medications to control blood pressure (e.g., ACE inhibitors or ARBs), diuretics for edema, and immunosuppressants in some cases. Dietary modifications, such as reduced salt and protein intake, may be recommended. Regular monitoring of kidney function is essential to adjust treatment as needed.

Prognosis and Follow-Up

Prognosis varies depending on the severity of glomerular changes and response to treatment. Some individuals may experience slow progression, while others may develop chronic kidney disease or require dialysis. Regular follow-up with a nephrologist is necessary to monitor kidney function, manage complications, and adjust therapy. Early intervention can help delay disease advancement.

Complications

• Chronic kidney disease (CKD) or end-stage renal disease (ESRD).
• Hypertension, which may worsen kidney damage.
• Edema and fluid retention.
• Increased risk of infections due to impaired kidney function.

Lifestyle & Prevention

• Maintain a balanced diet with controlled salt and protein intake.
• Monitor and manage blood pressure regularly.
• Avoid nephrotoxic medications (e.g., certain NSAIDs) unless prescribed.
• Stay hydrated and follow medical advice for fluid restrictions if needed.
• Engage in regular physical activity as tolerated, with physician guidance.

When to Seek Professional Help

Seek medical attention if you experience persistent hematuria, significant proteinuria, unexplained swelling, or changes in urine output. Prompt evaluation is important if hypertension develops or worsens, as these may indicate progressive kidney damage. Regular check-ups are recommended for those with a family history of hereditary nephropathy.

Tips for Medical Coders

When coding for N07.3, ensure documentation supports the presence of diffuse mesangial proliferative glomerulonephritis and confirms the hereditary nature of the nephropathy. Verify that the condition is not classified elsewhere (e.g., specific genetic nephropathies with defined codes). Include details about biopsy findings, genetic testing results, or family history if available to support the diagnosis. Accurate coding requires clear differentiation from other hereditary nephropathies and appropriate use of the ICD-10-CM code N07.3.